Cohen, J V <br/><br/>
Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy.  [electronic resource] 

 -  Familial cancer  Mar 2012 
 - 69-75 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7292 
<br/><br/><label>Standard No.: </label>10.1007/s10689-011-9480-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>BRCA1 Protein--genetics<br/>BRCA2 Protein--genetics<br/>Bone Diseases, Metabolic--diagnosis<br/>Breast Neoplasms--complications<br/>Coronary Artery Disease--diagnosis<br/>Depression--diagnosis<br/>Diabetes Mellitus--diagnosis<br/>Female<br/>Follow-Up Studies<br/>Heterozygote<br/>Humans<br/>Hyperlipidemias--diagnosis<br/>Hypertension--diagnosis<br/>Hypothyroidism--diagnosis<br/>Medical Records<br/>Middle Aged<br/>Mutation--genetics<br/>Myocardial Infarction--diagnosis<br/>Osteoporosis--diagnosis<br/>Ovarian Neoplasms--complications<br/>Ovariectomy<br/>Postoperative Complications<br/>Prognosis<br/>Retrospective Studies<br/>Risk Reduction Behavior